You are here

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Orange, California, 92868 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Melanoma, Skin Neoplasms
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Histologically documented melanoma with metastases

- No more than 1 prior systemic therapy for metastatic disease (prior adjuvant therapy
with interferon does not count as prior therapy for metastatic disease)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- History of hemoptysis (coughing up of blood)

- Brain metastases

NCT00094107
Pfizer
Completed
Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Melanoma Carcinoma
NCT00070642
All Genders
Part 1, MELANOMA, SCCHN, OVCA, SARCOMA, OTHER SOLID TUMORS, Part 1 and 2, NSCLC, UROTHELIAL CARCINOMA
NCT02573259
All Genders
18+
Years
Multiple Sites
Skin Neoplasms, Kidney Transplantation
NCT00129961
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now